CAMBRIDGE, Mass., Apr 11, 2002 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by the Nasdaq European Life Sciences Forum on Friday, April 19, 2002 at 12:15pm GMT (7:15am EDT). The presentation will be webcast live from the Langham Hilton Hotel, Portland Place in London and may be accessed under the investor relations tab at www.alkermes.com.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc.
Rebecca Peterson
Director, Investor Relations
(617) 583-6378